Affinity Whole Health（Carmel, IN）

Affinity Whole Health operates as a telehealth-focused clinic serving patients throughout Indiana from its Carmel base, concentrating on GLP-1 receptor agonist therapies and hormone optimization protocols. The clinic structures its services around remote consultations that allow patients across the Indianapolis metropolitan area and beyond to access prescription weight management and hormone therapy without requiring in-person visits. This telehealth model enables the clinic to serve working professionals, parents, and individuals with mobility constraints who need medical weight loss support but face scheduling or transportation barriers.

The clinic’s weight management program centers on two FDA-approved GLP-1 medications: semaglutide and liraglutide. Semaglutide, administered as a once-weekly subcutaneous injection, works by mimicking the glucagon-like peptide-1 hormone to reduce appetite, slow gastric emptying, and improve glycemic control in patients with elevated BMI. Liraglutide functions through similar mechanisms with a daily injection schedule, providing an alternative for patients who prefer more frequent dosing or have specific tolerability considerations. Affinity Whole Health’s providers conduct initial assessments to determine candidacy based on body mass index, metabolic health markers, previous weight loss attempts, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients receive detailed injection training, dosage titration schedules, and ongoing monitoring for side effects including nausea, gastrointestinal disturbances, and changes in heart rate.

The hormone therapy division addresses testosterone deficiency in men and broader hormone imbalances affecting both sexes. Providers evaluate symptoms such as fatigue, decreased libido, mood changes, difficulty building muscle mass, and cognitive fog alongside laboratory testing of total testosterone, free testosterone, estradiol, thyroid panels, and other relevant biomarkers. Treatment protocols may include testosterone replacement therapy delivered through injections, topical preparations, or pellet implants, with selection based on patient preference, lifestyle factors, and absorption characteristics. The clinic monitors patients for therapeutic response and potential adverse effects including polycythemia, prostate health changes, and estrogen conversion issues that require aromatase management. Female patients receive hormone assessments addressing perimenopause, menopause, thyroid dysfunction, and PCOS-related concerns, with treatment plans individualized to symptom presentation and lab findings.

Affinity Whole Health’s telehealth consultation process begins with patients completing comprehensive intake forms detailing medical history, current medications, previous hormone or weight management treatments, and specific health goals. Virtual appointments conducted via HIPAA-compliant video platforms allow providers to review this information, discuss treatment options, order necessary laboratory work through local draw stations in Indiana, and develop initial treatment protocols. Follow-up appointments occur at intervals determined by the treatment type—typically monthly during GLP-1 titration phases and quarterly for established hormone therapy patients. The clinic coordinates prescription fulfillment and medication delivery, provides injection supplies when applicable, and maintains communication channels for patients to report concerns or side effects between scheduled visits. This structure has generated consistent feedback in online reviews regarding responsiveness to questions and clarity of information provided about medication mechanisms and expected timelines.

With 166 five-star Google reviews, the Carmel clinic has established a patient base that frequently references the team’s communication approach and willingness to address individual concerns about treatment protocols. The telehealth model eliminates geographic restrictions within Indiana, allowing the clinic to serve patients in Fort Wayne, Bloomington, Evansville, and rural communities who lack local access to specialized weight management or hormone optimization providers. Affinity Whole Health positions itself as a resource for patients seeking medical supervision of GLP-1 therapies outside traditional endocrinology practices that may have extended wait times, and for individuals wanting hormone management integrated with metabolic health rather than isolated testosterone or thyroid treatment.